The fastest growing neurological disorder in the world is Parkinson’s disease. REM behavior disorder ( RBD) is the strongest prodromal risk factor for PD and related conditions. A landmark study aims to stop this trend.
The Parkinson’s Progression Markers Initiative (PPMI) was launched in 2010 by the Michael J. Fox Foundation for Parkinson’s Research to gather data and samples with the goal of enabling breakthroughs and accelerating the development of therapies to slow or stop the progression of Parkinson’s disease. PPMI is now re-opening enrollment to grow the number of volunteers seen in clinic at Northwestern University, with a particular focus on people with REM sleep behavior disorder or who act out dreams while asleep. Additional study details can be found at www.ppmionline.org.